Dennis J. Slamon, M.D., Ph.D., serves as director of Clinical/Translational Research, and as director of the Revlon/UCLA Women’s Cancer Research Program at JCCC. He is a professor of medicine, chief of the Division of Hematology/Oncology and executive vice chair for research for UCLA’s Department of Medicine. Slamon also serves as director of the medical advisory board for the National Colorectal Cancer Research Alliance, a fund-raising organization that promotes advances in colorectal cancer. For 12 years, Dr. Slamon and his colleagues conducted the laboratory and clinical research that led to the development of the new breast cancer drug Herceptin, which targets a specific genetic alteration found in about 25 percent of breast cancer patients. To acknowledge Slamon’s accomplishments, President Clinton appointed Slamon to the three-member President’s Cancer Panel in June 2000. A 1975 honors graduate of the University of Chicago’s Pritzker School of Medicine, Slamon earned his …Ph.D. in cell biology that same year. He completed his internship and residency at the University of Chicago Hospitals and Clinics, becoming chief resident in 1978. One year later, he became a fellow in the Division of Hematology/Oncology at UCLA.


Dr. Dennis Joseph Slamon, MD
0
The iMedixStars rating goes beyond a simple average of reviews. It’s calculated based on various factors, including the quantity, recency, and reliability of the reviews. Read More
Overwiew
Doctor Organizations
- Santa Monica Medical Center
Doctor Education
Medical School
1975
Univ Of Chicago Division Of Biological Sciences Pritzker School Of Medicine
Work Place
Ucla Santa Monica Parkside Cancer Care
2336 Santa Monica Blvd Ste 304
Santa Monica
CA
90404
USA
+13109984747
Specialties
Procedures performed
- Chemotherapy
Insurance Plans
- First Health PPO
- UHC West SignatureValue HMO
- CIGNA HMO
- PHCS PPO Kaiser
- Blue Cross CA Advantage PPO Preferred DirectAccess Plus
- Blue Shield CA Bronze Full PPO 4500
- Blue Shield CA PPO
- Blue Shield CA Silver 70 PPO
- Blue Cross CA Pathway X PPO
- Blue Cross CA PPO Prudent Buyer Individual
- Blue Cross CA PPO Prudent Buyer Large Group
- UHC SignatureValue Flex1
- CIGNA Open Access Plus
- Blue Cross CA Select PPO
- BCBS Blue Card PPO
- BS CA Platinum 90 PPO
- UHC Options PPO
- PHCS PPO
- Blue Cross CA California Care Large Group HMO
- Health Net CA Individual and Family PPO
- Anthem BC Pathway X EPO Network
- Blue Cross CA Select Plus HMO
- Blue Shield CA Access Plus HMO
- Aetna Choice POS II
- Blue Cross CA PPO Prudent Buyer Small Group
- BC CA California Care Small Group HMO
- Health Net CA HMO Employer Group
- Multiplan PPO
- Oscar Insurance CA
- CIGNA PPO
- Blue Shield CA Bronze 60 PPO SHOP
- UHC Choice Plus POS
- Blue Cross CA Vivity
- Health Net CA PPO
- Blue Shield CA Platinum Access+ HMO 25
- Aetna HMO
- Aetna Managed Choice POS Open Access
- LACare
- Aetna HMO Deductible Plan CA only
- Aexcel PPO
- Anthem Advantage HMO
- Health Net CA HMO
- MEDICA CHOICE WITH UNITEDHEALTHC
- UHC Nexus Open Access
- UHC SV Flex Tier 3
- Blue Cross CA Anthem Advantage HMO
- Blue Cross CA California Care Small Group HMO
- Blue Shield CA Platinum 90 PPO
- Blue Shield of CA 2021 I&F PPO Plan
- LA Care
- Medica Choice With UHC
- Oscar Circle EPO CA
- Oscar Northern CA Cigna + Oscar Open Access Plus
- Oscar Southern CA Employee
- UHC SignatureValue HMO - CA
- BCBS Pathway EPO
- Oscar CA Cigna + Oscar Open Access Plus
- Blue Cross CA Pathway EPO
Conditions
- Venous Embolism and Thrombosis
- Malignant Neoplasm of Colon
- Leukemia
- Non-Hodgkin's Lymphoma
- Malignant Neoplasm of Female Breast
- Reviews
- Q&A
0 total
- 5 0 %
- 4 0 %
- 3 0 %
- 2 0 %
- 1 0 %
There are no questions!
Leave a comment